- €2.20bn
- €2.16bn
- €1.11bn
Brief: Almirall And CrystalO To Discover, Develop Novel Small Molecules In Medical Dermatology
Almirall shares rise as lower costs beat EBITDA estimates
Brief: Almirall, Certest Biotec Sign Deal to Develop Rare Dermatology Treatments
Spanish stocks - Factors to watch on July 24
Spain's Almirall H1 net sales rise, reiterates 2026 guidance
Brief: Almirall H1 Sales EUR 602.7 Million
Brief: Almirall H1 Net Profit €39.6 Mln
Brief: Almirall Gets EMA Acceptance For Paediatric Ebglyss
Brief: Almirall Divests Its Actithiol Franchise for €15 Mln
Brief: Almirall Buys 20.3 Mln Rights For Gross Total Of €3.8 Mln
Brief: Almirall Amends Weighted Average Price Of Share For Scrip Dividend
Spanish stocks - Factors to watch on May 11
Brief: Almirall Approves Fully Paid-Up Capital Increase For Flexible Dividend
Brief: Almirall Q1 Normalized Net Profit 16.1 Mln Euros
Brief: Almirall Q1 Sales EUR 291 Million
Brief: Almirall Expands Collaboration With Barcelona Supercomputing Center To Boost Dermatology Research
Brief: Almirall Proposes Payment Of Dividend Out Of Unrestricted Reserves Of 40.8 Mln Euros
Brief: Almirall Says Lebrikizumab Shows Control in Atopic Dermatitis For Up To Four Years
Brief: Almirall Enters Collaboration With Huaota For Development Of Monoclonal Antibody In Medical Dermatology